Safety of Onartuzumab in Patients with Solid Tumors: Experience to Date from the Onartuzumab Clinical Trial Program.
Morley R, Cardenas A, Hawkins P, Suzuki Y, Paton V, Phan SC, Merchant M, Hsu J, Yu W, Xia Q, Koralek D, Luhn P, Aldairy W.
Morley R, et al. Among authors: merchant m.
PLoS One. 2015 Oct 7;10(10):e0139679. doi: 10.1371/journal.pone.0139679. eCollection 2015.
PLoS One. 2015.
PMID: 26445503
Free PMC article.